{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:35:32Z","timestamp":1793230532840,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006618.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:00:00Z","timestamp":1409097600000}}],"reference-count":49,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006618.pub3","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T18:58:43Z","timestamp":1409165923000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Methotrexate for induction of remission in ulcerative colitis"],"prefix":"10.1002","volume":"2014","author":[{"given":"Nilesh","family":"Chande","sequence":"first","affiliation":[{"name":"London Health Sciences Centre - Victoria Hospital; Room E6-321A 800 Commissioners Road East London ON Canada N6A 5W9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Robarts Research Institute; Robarts Clinical Trials; P.O. Box 5015 100 Perth Drive London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Robarts Research Institute; Robarts Clinical Trials; P.O. Box 5015 100 Perth Drive London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John WD","family":"McDonald","sequence":"additional","affiliation":[{"name":"Robarts Research Institute; Robarts Clinical Trials; P.O. Box 5015 100 Perth Drive London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD006618.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00042737-200012110-00010","article-title":"6-Mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease","volume":"12","author":"Mat\u00e9-Jim\u00e9nez","year":"2000","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD006618.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1053\/gast.1996.v110.pm8613046","article-title":"Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial","volume":"110","author":"Oren","year":"1996","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD006618.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/BF01296109","article-title":"Low-dose oral methotrexate in refractory inflammatory bowel disease","volume":"38","author":"Baron","year":"1993","journal-title":"Digesdtive Diseases and Sciences"},{"issue":"4","key":"10.1002\/14651858.CD006618.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2036.2005.02331.x","article-title":"Oral methotrexate in ulcerative colitis","volume":"21","author":"Cummings","year":"2005","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD006618.pub3-BIB0005|cit5","first-page":"175","article-title":"Long-term parenteral therapy with methotrexate in refractory ulcerative colitis. Preliminary results","volume":"7","author":"Dejica","year":"1998","journal-title":"Romanian Journal of Gastroenterology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD006618.pub3-BIB0006|cit6","first-page":"A227","article-title":"A randomized, single-blind, pharmacokinetic and dose response study of subcutaneous methotrexate, 15 and 25 mg\/week, for refractory ulcerative colitis and Crohn's disease","volume":"14","author":"Egan","year":"1998","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD006618.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1046\/j.1365-2036.1999.00667.x","article-title":"A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis","volume":"13","author":"Egan","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD006618.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00054725-199908000-00004","article-title":"Plasma and rectal adenosine in inflammatory bowel disease: effect of methotrexate","volume":"5","author":"Egan","year":"1999","journal-title":"Inflammatory Bowel Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006618.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00054725-200011000-00005","article-title":"Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease","volume":"6","author":"Egan","year":"2000","journal-title":"Inflammatory Bowel Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006618.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1365-2036.2002.01227.x","article-title":"The efficacy of methotrexate for maintaining remission in inflammatory bowel disease","volume":"16","author":"Fraser","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD006618.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"A525","DOI":"10.1016\/S0016-5085(03)82658-6","article-title":"Parenteral methotrexate is not effective treatment for refractory ulcerative colitis","volume":"124","author":"Fraser","year":"2003","journal-title":"Gastroenterology"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD006618.pub3-BIB0012|cit12","first-page":"A661","article-title":"Subcutaneous methotrexate: a safe and effective therapy in IBD","volume":"130","author":"Gibson","year":"2006","journal-title":"Gastroenterology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD006618.pub3-BIB0014|cit13","first-page":"A662","article-title":"Efficacy and safety of methotrexate therapy in inflammatory bowel disease. The Madrid experience","volume":"136","author":"Gonz\u00e1lez-Lama","year":"2009","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD006618.pub3-BIB0013|cit14","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/MEG.0b013e3283556db5","article-title":"Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience","volume":"24","author":"Gonz\u00e1lez-Lama","year":"2012","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD006618.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1016\/S0016-5085(13)61584-X","article-title":"A comparison of efficacy, pharmacokinetics and immunogenicity in patients with ulcerative colitis receiving infliximab monotherapy versus combination therapy","volume":"144","author":"Hayes","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD006618.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/jgh.12517","article-title":"Comparison of efficacy, pharmacokinetics, and immunogenicity between infliximab mono- versus combination therapy in ulcerative colitis","volume":"29","author":"Hayes","year":"2014","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"10","key":"10.1002\/14651858.CD006618.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/01.fpc.0000172242.19675.33","article-title":"The pharmacogenetics of methotrexate in inflammatory bowel disease","volume":"15","author":"Herrlinger","year":"2005","journal-title":"Pharmacogenetics and Genomics"},{"issue":"51","key":"10.1002\/14651858.CD006618.pub3-BIB0018|cit18","first-page":"2552","article-title":"Methotrexate as possible treatment in refractory chronic inflammatory intestinal disease","volume":"138","author":"Houben","year":"1994","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"key":"10.1002\/14651858.CD006618.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S690","DOI":"10.14309\/00000434-201210001-01704","article-title":"Methotrexate in ulcerative colitis: a nationwide retrospective cohort from the Veteran Affairs Healthcare System","volume":"107","author":"Khan","year":"2012","journal-title":"American Journal of Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD006618.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/MIB.0b013e31828133e8","article-title":"Methotrexate in ulcerative colitis: a nationwide retrospective cohort from the Veteran Affairs Health Care System","volume":"19","author":"Khan","year":"2013","journal-title":"Inflammatory Bowel Diseases"},{"issue":"5","key":"10.1002\/14651858.CD006618.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-110-5-353","article-title":"Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease","volume":"110","author":"Kozarek","year":"1989","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl","key":"10.1002\/14651858.CD006618.pub3-BIB0022|cit22","first-page":"A648","article-title":"Long-term use of methotrexate in inflammatory bowel disease: severe disease 3, drug therapy 2. Seventh inning stretch","volume":"102","author":"Kozarek","year":"1992","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD006618.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.crohns.2011.03.012","article-title":"Methotrexate in ulcerative colitis: a Spanish multicentric study on clinical use and efficacy","volume":"5","author":"Ma\u00f1osa","year":"2011","journal-title":"Journal of Crohn's and Colitis"},{"issue":"10","key":"10.1002\/14651858.CD006618.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1046\/j.1365-2036.2002.01340.x","article-title":"Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission","volume":"16","author":"Paoluzi","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD006618.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2036.2012.05175.x","article-title":"Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study","volume":"36","author":"Richter","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD006618.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.dld.2011.09.015","article-title":"The use of methotrexate for treatment of inflammatory bowel disease in clinical practice","volume":"44","author":"Saibeni","year":"2012","journal-title":"Digestive and Liver Disease"},{"issue":"3","key":"10.1002\/14651858.CD006618.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2036.2003.01480.x","article-title":"Methotrexate in ulcerative colitis","volume":"17","author":"Siveke","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD006618.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00042737-200409000-00018","article-title":"Experience with the use of low-dose methotrexate for inflammatory bowel disease","volume":"16","author":"Soon","year":"2004","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD006618.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1111\/j.1572-0241.2000.03287.x","article-title":"Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease","volume":"95","author":"Te","year":"2000","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD006618.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2036.2009.04073.x","article-title":"Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine \/mercaptopurine","volume":"30","author":"Wahed","year":"2009","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD006618.pub3-BIB0031|cit31","unstructured":"A controlled, randomized, double-blind, multicenter study, comparing methotrexate versus placebo in steroid-refractory ulcerative colitis (METEOR) Ongoing study September, 2007"},{"key":"10.1002\/14651858.CD006618.pub3-BIB0032|cit32","unstructured":"Randomized, double blind, prospective trial investigating the efficacy of methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC) Ongoing study February 2012"},{"issue":"1","key":"10.1002\/14651858.CD006618.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/gut.2005.068809","article-title":"Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis","volume":"55","author":"Ardizzone","year":"2006","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD006618.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.MIB.0000197547.80558.59","article-title":"Revolution and evolution: 30 years of ileoanal pouch surgery","volume":"12","author":"Bach","year":"2006","journal-title":"Inflammatory Bowel Diseases"},{"issue":"5","key":"10.1002\/14651858.CD006618.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199502023320503","article-title":"Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators","volume":"332","author":"Feagan","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"22","key":"10.1002\/14651858.CD006618.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM200006013422202","article-title":"A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators","volume":"342","author":"Feagan","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"7650","key":"10.1002\/14651858.CD006618.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"6844","key":"10.1002\/14651858.CD006618.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/bmj.305.6844.20","article-title":"Randomised controlled trial of azathioprine withdrawal in ulcerative colitis","volume":"305","author":"Hawthorne","year":"1992","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006618.pub3-BIB0039|cit39","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"5945","key":"10.1002\/14651858.CD006618.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/bmj.4.5945.627","article-title":"Azathioprine in ulcerative colitis: final report on controlled therapeutic trial","volume":"4","author":"Jewell","year":"1974","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD006618.pub3-BIB0041|cit41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005112.pub2","article-title":"Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis","author":"Lawson","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD006618.pub3-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000957.pub2","article-title":"Methotrexate for treating rheumatoid arthritis","author":"Lopez-Olivo","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD006618.pub3-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003459.pub3","article-title":"Methotrexate for induction of remission in refractory Crohn's disease","author":"McDonald","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD006618.pub3-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006884.pub3","article-title":"Methotrexate for maintenance of remission in Crohn's disease","author":"Patel","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"23","key":"10.1002\/14651858.CD006618.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006618.pub3-BIB0046|cit46","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Sch\u00fcnemann","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD006618.pub3-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004277.pub2","article-title":"Cyclosproine A for induction of remission in severe ulcerative colitis","author":"Shibolet","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD006618.pub3-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000478.pub3","article-title":"Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis","author":"Timmer","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD006618.pub3-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006618.pub2","article-title":"Methotrexate for induction of remission in ulcerative colitis","author":"Chande","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006618.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T11:50:29Z","timestamp":1711713029000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006618.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006618.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]}}}